Alpha Tau Medical Ltd. DRTS NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • IL • USD

SharesGrow Score

49/100

2/6 Pass

SharesGrow Intrinsic Value

कुल 50 हाल के अंदरूनी लेनदेन दर्ज हैं Alpha Tau Medical Ltd. (DRTS), जिसमें शामिल हैं 0 खरीद और 0 बिक्री.

हाल की गतिविधि वाले उल्लेखनीय अंदरूनी लोगों में शामिल हैं Levy Raphi, Milch David Mark, Kidron Nadav. अंदरूनी लेनदेन से पता चल सकता है कि कंपनी का नेतृत्व स्टॉक के मूल्यांकन और भविष्य की संभावनाओं को कैसे देखता है.

इनसाइडर ट्रेडिंग — DRTS

तिथि	नाम	भूमिका	लेनदेन प्रकार	शेयर	औसत मूल्य	मूल्य	स्वामित्व वाले शेयर
2026-04-01	Levy Raphi	Chief Financial Officer	अज्ञात	158,882	$6.41	$1.02M	-
2026-03-18	Milch David Mark	Director	अज्ञात	49,000	$11.50	$563.5K	-
2026-03-18	Kidron Nadav	Director	अज्ञात	15,527	$6.41	$99.53K	-
2026-03-18	Blumenfeld S Morry	Director	अज्ञात	15,527	$6.41	$99.53K	-
2026-03-18	Alon Ruth	Director	अज्ञात	15,527	$6.41	$99.53K	-
2026-03-18	Avruch Michael	Director	अज्ञात	15,527	$6.41	$99.53K	-
2026-03-18	Sofer Uzi	Chief Executive Officer	अज्ञात	396,680	$7.32	$2.9M	-
2026-03-18	Adler Alan	Director	अज्ञात	15,527	$6.41	$99.53K	-
2026-03-18	Levy Raphi	Chief Financial Officer	अज्ञात	-	-	-	23,996
2026-03-18	Netser Maya	Director	अज्ञात	15,527	$6.41	$99.53K	-
2025-06-17	Milch David Mark	Director	अज्ञात	24,460	$4.05	$99.06K	-
2025-06-17	Blumenfeld S Morry	Director	अज्ञात	24,460	$4.05	$99.06K	-
2025-06-17	Alon Ruth	Director	अज्ञात	24,460	$4.05	$99.06K	-
2025-06-17	Avruch Michael	Director	अज्ञात	24,460	$4.05	$99.06K	-
2025-06-17	Sofer Uzi	Chief Executive Officer	अज्ञात	24,460	$4.05	$99.06K	-
2025-06-17	Adler Alan	Director	अज्ञात	24,460	$4.05	$99.06K	-
2025-06-12	Kidron Nadav	Director	अज्ञात	35,554	$2.79	$99.2K	-
2025-04-01	Sofer Uzi	Chief Executive Officer	अज्ञात	674,238	$3.07	$2.07M	-
2025-04-01	Levy Raphi	Chief Financial Officer	अज्ञात	267,641	$2.60	$695.87K	-
2025-01-17	Netser Maya	Director	अज्ञात	24,048	$4.05	$97.39K	-
2024-12-17	Milch David Mark	Director	अज्ञात	43,257	$2.98	$128.91K	-
2024-12-17	Blumenfeld S Morry	Director	अज्ञात	43,257	$2.98	$128.91K	-
2024-12-17	Alon Ruth	Director	अज्ञात	43,257	$2.98	$128.91K	-
2024-12-17	Avruch Michael	Director	अज्ञात	43,257	$2.98	$128.91K	-
2024-12-17	Sofer Uzi	Chief Executive Officer	अज्ञात	43,257	$2.98	$128.91K	-
2024-12-17	Adler Alan	Director	अज्ञात	43,257	$2.98	$128.91K	-
2024-04-01	Sofer Uzi	Chief Executive Officer	अज्ञात	763,843	$3.48	$2.66M	-
2024-04-01	Levy Raphi	Chief Financial Officer	अज्ञात	301,880	$2.98	$899.6K	-
2024-01-01	Blumenfeld S Morry	Director	अज्ञात	46,905	$3.28	$153.85K	-
2024-01-01	Avruch Michael	Director	अज्ञात	46,905	$3.28	$153.85K	-
2024-01-01	Sofer Uzi	Chief Executive Officer	अज्ञात	46,905	$3.28	$153.85K	-
2024-01-01	Adler Alan	Director	अज्ञात	46,905	$3.28	$153.85K	-
2023-11-01	Milch David Mark	Director	अज्ञात	46,905	$3.28	$153.85K	-
2023-11-01	Alon Ruth	Director	अज्ञात	46,905	$3.28	$153.85K	-
2023-04-01	Sofer Uzi	Chief Executive Officer	अज्ञात	1,102,653	$3.57	$3.94M	-
2023-04-01	Levy Raphi	Chief Financial Officer	अज्ञात	328,458	$3.28	$1.08M	-
2022-11-02	Blumenfeld S Morry	Director	अज्ञात	10,657	$7.19	$76.62K	-
2022-11-02	Avruch Michael	Director	अज्ञात	10,657	$7.19	$76.62K	-
2022-11-02	Adler Alan	Director	अज्ञात	10,657	$7.19	$76.62K	-
2022-06-07	Blumenfeld S Morry	Director	अज्ञात	24,727	$11.50	$284.36K	-
2022-06-07	Avruch Michael	Director	अज्ञात	24,727	$11.50	$284.36K	-
2022-06-07	Sofer Uzi	Chief Executive Officer	अज्ञात	250,933	$7.19	$1.8M	-
2022-06-07	Adler Alan	Director	अज्ञात	24,727	$11.50	$284.36K	-
2022-06-07	Levy Raphi	Chief Financial Officer	अज्ञात	80,360	$7.19	$577.79K	-
2022-04-21	Alon Ruth	Director	अज्ञात	10,178	$7.19	$73.18K	-
2022-04-07	Milch David Mark	Director	अज्ञात	10,178	$7.19	$73.18K	-
2022-03-07	Levy Raphi	Chief Financial Officer	अज्ञात	90,529	$4.03	$364.83K	-
2020-09-03	Levy Raphi	Chief Financial Officer	अज्ञात	45,265	$4.42	$200.07K	-
2019-03-01	Blumenfeld S Morry	Director	अज्ञात	54,318	$4.42	$240.09K	-
2019-03-01	Avruch Michael	Director	अज्ञात	54,318	$4.42	$240.09K	-

■ जानकारीपूर्ण — खुले बाजार में खरीद/बिक्री (सर्वाधिक महत्वपूर्ण) ■ गैर-जानकारी खरीद — पुरस्कार, विकल्प अभ्यास, रूपांतरण ■ गैर-जानकारी बिक्री — कर रोक, पुरस्कार बिक्री ■ तटस्थ — उपहार, ट्रस्ट, समाप्ति